Last updated on February 2018
DNS-3379 vs. Placebo in Stroke Rehabilitation
Brief description of study
This is a randomized, double-blind, placebo-controlled parallel group outpatient 42-day treatment study that will utilize standard stroke rehabilitation outcome measures to evaluate the effect of DNS-3379 on upper extremity motor recovery in subjects following ischemic stroke.
Clinical Study Identifier: NCT03254160